Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2022
Jan. 31, 2021
Current assets:    
Cash and cash equivalents $ 321,426 $ 68,037
Marketable securities 210,983 212,652
Accounts receivable, net of allowance for doubtful accounts of $2.7 million and $3.2 million, respectively 163,681 116,278
Prepaid expenses and other current assets 109,167 101,096
Total current assets 805,257 498,063
Property and equipment, net 14,705 9,011
Goodwill 50,706 47,427
Other non-current assets 49,378 42,512
Total assets 920,046 597,013
Current liabilities:    
Accounts payable 15,802 16,955
Accrued expenses and other current liabilities 100,220 63,170
Debt, short-term 0 0
Deferred revenue 279,028 221,439
Total current liabilities 395,050 301,564
Long term debt 0 78,848
Deferred revenue less current portion 5,325 19,873
Deferred tax liability, long-term 1,101 869
Other liabilities, long-term 2,721 2,006
Total liabilities 404,197 403,160
Commitments and contingencies
Stockholders’ deficit    
Preferred stock 0  
Common stock   4
Treasury stock, at cost, 14,130,784 shares as of January 31, 2022 and 2021, respectively (23,831) (23,831)
Additional paid-in capital 982,122 122,061
Accumulated other comprehensive loss (income) (820) 787
Accumulated deficit (441,630) (330,160)
Total stockholders’ deficit 515,849 193,853
Total liabilities and stockholders’ deficit 920,046 597,013
Convertible Preferred Stock    
Stockholders’ deficit    
Preferred stock   $ 424,992
A    
Stockholders’ deficit    
Common stock 3  
B    
Stockholders’ deficit    
Common stock $ 5